Legal & General Group Plc - CELLULAR BIOMEDICINE GROUP I ownership

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of CELLULAR BIOMEDICINE GROUP I
ValueSharesWeighting
Q4 2020$25,0000.0%1,3700.0%0.00%
Q3 2020$25,000
-10.7%
1,370
-27.0%
0.00%
Q2 2020$28,000
-6.7%
1,876
-3.5%
0.00%
Q1 2020$30,000
-30.2%
1,944
-26.1%
0.00%
Q4 2019$43,000
+26.5%
2,629
+15.4%
0.00%
Q3 2019$34,0000.0%2,2780.0%0.00%
Q2 2019$34,000
+13.3%
2,278
+31.8%
0.00%
Q1 2019$30,000
-3.2%
1,7280.0%0.00%
Q4 2018$31,0000.0%1,7280.0%0.00%
Q3 2018$31,000
-8.8%
1,7280.0%0.00%
Q2 2018$34,000
-8.1%
1,728
-43.8%
0.00%
Q1 2017$37,000
-31.5%
3,076
-24.5%
0.00%
Q4 2016$54,000
+74.2%
4,076
+85.9%
0.00%
Q3 2016$31,000
+24.0%
2,1920.0%0.00%
Q2 2016$25,0002,1920.00%
Other shareholders
CELLULAR BIOMEDICINE GROUP I shareholders Q3 2023
NameSharesValueWeighting ↓
S. MUOIO & CO. LLC 52,468$964,0001.05%
Olympiad Research LP 54,795$1,007,0000.58%
Alpine Global Management, LLC 119,902$2,204,0000.45%
GABELLI & Co INVESTMENT ADVISERS, INC. 65,922$1,212,0000.19%
First Trust Capital Management L.P. 32,688$601,0000.17%
GLAZER CAPITAL, LLC 232,103$4,266,0000.15%
Walleye Capital LLC 105,000$1,930,0000.13%
Yakira Capital Management, Inc. 17,588$323,0000.08%
Dynamic Technology Lab Private Ltd 17,929$330,0000.05%
EQUITEC PROPRIETARY MARKETS, LLC 10,600$195,0000.05%
View complete list of CELLULAR BIOMEDICINE GROUP I shareholders